{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:00:31Z","timestamp":1762459231878},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.atherosclerosis.2014.07.013","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T16:15:23Z","timestamp":1405959323000},"page":"230-236","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?"],"prefix":"10.1016","volume":"236","author":[{"given":"Susanne Elisabeth","family":"Hosbond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel Cosmus Pyndt","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Saaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Melholt","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jess","family":"Lambrechtsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Munkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Peter R\u00f8nnow","family":"Sand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oke","family":"Gerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina Svenstrup","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Mickley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0025-7125(03)00065-8","article-title":"Osteoporosis","volume":"87","author":"Brown","year":"2003","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.07.013_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.07.013_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","article-title":"Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells","volume":"280","author":"Hofbauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.07.013_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00125-004-1652-8","article-title":"Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha","volume":"48","author":"Olesen","year":"2005","journal-title":"Diabetologia"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2014.07.013_bib6","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-08-0554","article-title":"The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review","volume":"159","author":"Nybo","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS20050058","article-title":"Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction","volume":"109","author":"Crisafulli","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.07.013_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"issue":"1-2","key":"10.1016\/j.atherosclerosis.2014.07.013_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cca.2008.02.008","article-title":"Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number","volume":"391","author":"Palazzuoli","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2143\/AC.63.5.2033230","article-title":"Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome","volume":"63","author":"Ren","year":"2008","journal-title":"Acta Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.07.013_bib14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/14017431.2012.685491","article-title":"Osteoprotegerin as a marker of atherosclerosis: a systematic update","volume":"46","author":"Hosbond","year":"2012","journal-title":"Scand Cardiovasc J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjcard.2011.09.043","article-title":"Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis","volume":"109","author":"Mogelvang","year":"2012","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2459\/JCM.0b013e3283561433","article-title":"Serum osteoprotegerin and carotid intima-media thickness in acute\/chronic coronary artery diseases","volume":"14","author":"Ciccone","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown )"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2796.2009.02163.x","article-title":"Osteoprotegerin concentrations and prognosis in acute ischaemic stroke","volume":"267","author":"Jensen","year":"2010","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.07.013_bib19","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1538-7836.2010.03833.x","article-title":"Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease","volume":"8","author":"Jono","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.07.013_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2006.03.002","article-title":"Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans","volume":"191","author":"Vik","year":"2007","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1538-7836.2010.03790.x","article-title":"Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population\u2013the Tromso study","volume":"8","author":"Vik","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.07.013_bib24","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/0002-9149(94)90563-0","article-title":"Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis","volume":"74","author":"Agatston","year":"1994","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.07.013_bib25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2014.07.013_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study","volume":"56","author":"Erbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2014.07.013_bib27","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1475-097X.2005.00643.x","article-title":"Observer reproducibility and validity of systems for clinical classification of angina pectoris: comparison with radionuclide imaging and coronary angiography","volume":"26","author":"Christensen","year":"2006","journal-title":"Clin Physiol Funct Imaging"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.07.013_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1741826711409172","article-title":"Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study","volume":"19","author":"Diederichsen","year":"2012","journal-title":"Eur J Prev Cardiol"},{"issue":"2 Pt 1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0735-1097(83)80093-X","article-title":"A clinically relevant classification of chest discomfort","volume":"1","author":"Diamond","year":"1983","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.07.013_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.07.013_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjmed.2013.02.029","article-title":"Classification of myocardial infarction: frequency and features of type 2 myocardial infarction","volume":"126","author":"Saaby","year":"2013","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2014.07.013_bib33","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2014.07.013_bib34","series-title":"Statistics with confidence","article-title":"Proportions and their differences","author":"Newcombe","year":"2000"},{"key":"10.1016\/j.atherosclerosis.2014.07.013_bib35","series-title":"Statistical methods in diagnostic medicine","author":"Zhou","year":"2011"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.07.013_bib36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.07.013_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","article-title":"Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease","volume":"47","author":"Mesquita","year":"2009","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.07.013_bib38","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1016\/j.transproceed.2010.09.129","article-title":"Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease","volume":"42","author":"Mesquita","year":"2010","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.07.013_bib39","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/ndt\/gfp301","article-title":"A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients","volume":"24","author":"Morena","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib40","doi-asserted-by":"crossref","first-page":"e36175","DOI":"10.1371\/journal.pone.0036175","article-title":"Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients","volume":"7","author":"Morena","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.07.013_bib41","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2005.12.054","article-title":"The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects","volume":"47","author":"Anand","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00592-009-0154-z","article-title":"The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM","volume":"47","author":"Jung","year":"2010","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.07.013_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2006.08.064","article-title":"Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)","volume":"99","author":"Abedin","year":"2007","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.07.013_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.atherosclerosis.2010.06.027","article-title":"Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris","volume":"212","author":"Pedersen","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.07.013_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(03)00090-5","article-title":"Serum levels of osteoprotegerin increase with age in a healthy adult population","volume":"32","author":"Kudlacek","year":"2003","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.07.013_bib46","first-page":"148","article-title":"Heparin induces mobilization of osteoprotegerin into the circulation","volume":"98","author":"Vik","year":"2007","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2014.07.013_bib47","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/eurheartj\/ehi433","article-title":"Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris","volume":"26","author":"Cosin-Sales","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.07.013_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2008.03.010","article-title":"Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease","volume":"201","author":"Inoue","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2011.04.007","article-title":"Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?","volume":"217","author":"Kastrup","year":"2012","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.07.013_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00365513.2011.586470","article-title":"Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease","volume":"71","author":"Mathiasen","year":"2011","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014012891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014012891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T11:02:26Z","timestamp":1689418946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014012891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0021915014012891"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.07.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}